LCN2 and acute kidney injury: These biomarkers enable early detection of AKI, which is crucialfor timely intervention and reducing the risk of long-term renal impairment.Moreover, elevated levels of NGAL, cystatin C, and KIM-1 are strongly associatedwith adverse outcomes, including prolonged hospital stays and increasedmortality.